Page last updated: 2024-08-24

trofosfamide and Astrocytoma, Grade IV

trofosfamide has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gnekow, A; Kuehl, J; Mölenkamp, G; Rating, D; Warmuth-Metz, M; Westphal, S; Wolff, JE	1
Benesch, M; Berthold, F; Gnekow, AK; Kortmann, RD; Pietsch, T; Rutkowski, S; Sträter, R; Wagner, S; Warmuth-Metz, M; Wolff, JE	1
Gnekow, A; Kortmann, RD; Kuehl, J; Mölenkamp, G; Pietsch, T; Westphal, S; Wolff, JE	1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J	1

Trials

2 trial(s) available for trofosfamide and Astrocytoma, Grade IV

Article	Year
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Pons; Postoperative Care; Survival Rate; Treatment Outcome	2002
Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer, 2000, Nov-15, Volume: 89, Issue:10 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Humans; Male; Pilot Projects; Postoperative Care; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome	2000

Article

Year

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.

British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9

Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Pons; Postoperative Care; Survival Rate; Treatment Outcome

2002

Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme.

Cancer, 2000, Nov-15, Volume: 89, Issue:10

Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Humans; Male; Pilot Projects; Postoperative Care; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome

2000

Other Studies

2 other study(ies) available for trofosfamide and Astrocytoma, Grade IV

Article	Year
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. British journal of cancer, 2006, Oct-23, Volume: 95, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine	2006
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. Journal of neuro-oncology, 2000, Volume: 48, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53	2000

Article

Year

Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.

British journal of cancer, 2006, Oct-23, Volume: 95, Issue:8

Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine

2006

Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.

Journal of neuro-oncology, 2000, Volume: 48, Issue:2

Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53

2000